Yoshikane Kikushige

TIM-3 Is a Promising Target to Selectively Kill Acute Myeloid Leukemia Stem Cells

Yoshikane Kikushige, Takahiro Shima, Shin‐ichiro Takayanagi et al. · Cell stem cell · 2010 · 475 citations · Full text

Hematological Malignancy, Cell Therapy, Medicine +10

Self-Renewing Hematopoietic Stem Cell Is the Primary Target in Pathogenesis of Human Chronic Lymphocytic Leukemia

Yoshikane Kikushige, Fumihiko Ishikawa, Toshihiro Miyamoto et al. · Cancer Cell · 2011 · 301 citations · Full text

Hematological Malignancy, Medicine, Stem Cell Mobilization +9

A TIM-3/Gal-9 Autocrine Stimulatory Loop Drives Self-Renewal of Human Myeloid Leukemia Stem Cells and Leukemic Progression

Yoshikane Kikushige, Toshihiro Miyamoto, Junichiro Yuda et al. · Cell stem cell · 2015 · 273 citations · Full text

Hematological Malignancy, Cell Therapy, Mixed-phenotype Acute Leukemia +6

FLT3-ITD up-regulates MCL-1 to promote survival of stem cells in acute myeloid leukemia via FLT3-ITD–specific STAT5 activation

Goichi Yoshimoto, Toshihiro Miyamoto, Siamak Jabbarzadeh‐Tabrizi et al. · Blood · 2009 · 256 citations · Full text

Acquired Initiating Mutations in Early Hematopoietic Cells of CLL Patients

Frédérik Damm, Elena Mylonas, Adrien Cosson et al. · Cancer Discovery · 2014 · 243 citations